Clinical Studies

MERITAGE

This is a feasibility study, now in development. Planned to begin in two sites, one in the US and one in the UK, it will evaluate epimacular beta radiation therapy when used to treat wet AMD drug persistence in those patients who have received anti-VEGF therapy.